Khurshid, H., Dipetrillo, T., Ng, T., Mantripragada, K., Birnbaum, A., Berz, D., … & Safran, H. (2012). Frontiers in Oncology A phase I study of dasatinib with concurrent chemoradiation for stage III non-small cell lung cancer.
Paclitaxel poliglumex, temozolomide, and radiation for newly diagnosed high-grade glioma: a Brown University Oncology Group Study.Jeyapalan S, Boxerman J, Donahue J, Goldman M, Kinsella T, Dipetrillo T, Evans D, Elinzano H, Constantinou M, Stopa E, Puthawala Y, Cielo D, Santaniello A, Oyelese A, Mantripragada K, Rosati K, Isdale D, Safran H; Brown University Oncology Group Study.Am J Clin Oncol. 2014 Oct;37(5):444-9. doi: 10.1097/COC.0b013e31827de92b.PMID: 23388562
Lenalidomide for second-line treatment of advanced hepatocellular cancer: a Brown University oncology group phase II study
Howard Safran 1, Kevin P Charpentier, Andreas Kaubisch, Kalyan Mantripragada, Gregory Dubel, Kimberly Perez, Katherine Faricy-Anderson, Thomas Miner, Yoko Eng, Joel Victor, Angela Plette, Joseph Espat, Pamela Bakalarski, Patti Wingate, David Berz, Denise Luppe, Diane Martel, Kayla Rosati, Santiago Aparo PMID: 23648434 DOI: 10.1097/COC.0b013e3182868c66
Mantripragada, K., & Khurshid, H. (2013). Targeting genomic alterations in squamous cell lung cancer. Frontiers in oncology, 3.
Mantripragada, K., Reagan, J. L., Quesenberry, P. J., & Fast, L. D. (2014). Advances in cellular therapy for the treatment of leukemia. Discovery medicine , 17(91), 15-24.
Mantripragada, K., & Birnbaum, A. (2015). Response to Anti-PD-1 Therapy in Metastatic Merkel Cell Carcinoma Metastatic to the Heart and Pancreas. Cureus 7(12): e403.
Reagan, J. L., Fast, L. D., Nevola, M., Mantripragada, K., Mulder, A., Claas, F. H. J., … & Quesenberry, M. I. (2015). Nonengraftment donor lymphocyte infusions for refractory acute myeloid leukemia. Blood cancer journal, 5(12), e371.
Elinzano, , Glantz, M., Mrugala, M., Kesari, S., Piccioni, D. E., Kim, L., Pan, E., Shakeeb, Y., Coyle, T., Kinsella, T., Evans, D., Mantripragada, K., … & Evans, D. (2015). PPX and Concurrent Radiation for Newly Diagnosed Glioblastoma Without MGMT Methylation: A Randomized Phase II Study: BrUOG 244. American journal of clinical oncology.
Mantripragada, C., Olszewski, A. J., Schumacher, A., Perez, K., Birnbaum, A., Reagan, J. L., … & Safran, H. (2016). ReCAP: Clinical Trial Accrual Targeting Genomic Alterations After Next-Generation Sequencing at a Non-National Cancer Institute–Designated Cancer Program.
Mantripragada, C., Fircanis, R. S., Reagan, J. L., & LeGolvan, M. (2016). Acquired Syphilis With Anemia and Leukoerythroblastic Reaction: A Case Report. Annals of internal medicine.
Mantripragada, C., & Safran, H. (2016). Optimizing initial chemotherapy for metastatic pancreatic cancer. Future Oncology.
Olszewski, J., Mantripragada, K. C., Castillo, J. (2016). Risk Factors for Early Death After Rituximab-Based Immunochemotherapy in Older Patients With Diffuse Large B-Cell Lymphoma. Journal of the National Comprehensive Cancer Network . 14:1121-29.
Mantripragada, C., Hamid, F., Shafquat, H., Olszewski, A. J. (2017). Adjuvant Therapy for Resected Gallbladder Cancer: Analysis of the National Cancer Data Base. Journal of the National Cancer Institute . 109 (2): djw202.
Mantripragada & Quesenberry, P. J. (2017). Polarization of neutrophil granules — A characteristic of inflammatory states. Blood Cells, Molecules, and Diseases, Available online 25 September 2017, ISSN 1079-9796,
ABSTRACTS AND POSTER PRESENTATIONS
- Chun, K., Chamarthy, M., Feng, J., Tokayer, A., Behin, D., Mantripragada, K., … & Freeman, L. (2008). Various patterns of gastric emptying: A comparison of half time with four-hour retention. Journal of Nuclear Medicine, 49(supplement 1), 39P-39P.
- Chamarthy, M., Chun, K., Tokayer, A., Mantripragada, K., Feng, J., Goldfarb, R., & Freeman, L. (2008). Role of multiple end point testing to detect various patterns of gastric emptying disorders.
- Safran, H., Charpentier, K., Kaubisch, A., Dubel, G., Perez, K., Faricy-Anderson, K., Miner, T., Mantripragada, K.. … & Isdale, D. (2012, June). Lenalidomide for Second-Line Treatment of Advanced Hepatocellular Cancer: A Brown University Oncology Group Phase II Study. Journal of Clinical Oncology, (Vol. 30, No. 15_suppl, p. 2318).
- Safran, H., Charpentier, K., Perez, K., Mantripragada, K., Austin, T. C., Nadeem, O., … & Mitchell, K. (2014, January). FOLFOX and nab-paclitaxel (nab-P) for advanced pancreatic cancer: A phase I study. Journal of Clinical Oncology, (Vol. 32, No. 3_suppl, p. 258).
- Safran, H., Perez, K., Charpentier, K., Austin, T. C., Mantripragada, K. C., Bishop, K. D., … & Martel, D. (2014, May). Nab-paclitaxel (nab-P) combined with FOLFOX for advanced pancreatic cancer: A phase I study. Journal of Clinical Oncology, (Vol. 32, No. 15_suppl, p. 4123).